Alterity Therapeutics Limited (market cap: $40 million), a pharmaceutical company specializing in the development of therapeutic drugs, has secured A$40 million in funding to advance the development ...

Alterity Therapeutics (ATHE) has received binding commitments for a capital raising of A$40M via a two tranche placement of fully paid ordinary ...

Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders – – Capital raising was strongly supported by domestic and international institutional investors – MELBOURNE, ...

A mixed US jobs report and Trump’s announcement of new 25 per cent tariffs on aluminium and steel imports sent Australian ...

Ansell has moved to expand its manufacturing presence beyond China, to countries including India and Sri Lanka.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

MST Financial is managing the raise and has split it into two tranches. Shares were placed in a trading halt on Thursday.

CD&R has named Sam Camens as managing director. In this role, Camens will drive CD&R’s health and welfare strategy. Previously, he was managing director of insurance and benefits at Onex. He is the ...

Alterity Therapeutics Ltd. ( ($AU:ATH) ) has shared an announcement. Alterity Therapeutics Limited has announced the issuance ...

Healthcare stocks are facing steep losses as several names have either manufacturing facilities in the tariffed countries and ...

This week’s ASX Bulls N’ Bears Runner of the Week is… Bio-Gene Technology. The company’s shares leapt after revealing it ...

This week’s Bulls N’ Bears Runner of the Week is… Bio-Gene Technology. The company’s shares leapt after revealing it scored a slice of two US defence grants.